Skip to main content

Childhood Cancer Survivors Face Socioeconomic Difficulties

Medically reviewed by Carmen Pope, BPharm. Last updated on April 16, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, April 15, 2024 -- Childhood cancer survivors face socioeconomic difficulties, according to a review published online April 15 in JAMA Pediatrics.

Márk Viktor Hernádfői, M.D., from the Centre for Translational Medicine at Semmelweis University in Budapest, Hungary, and colleagues conducted a systematic review and meta-analysis of 280 articles, reporting on 389,502 survivors to examine the socioeconomic attainment of childhood cancer survivors compared to their unaffected peers.

The researchers found that childhood cancer survivors were less likely to complete higher levels of education compared with population-based controls (odds ratio, 0.69; 95 percent confidence interval, 0.40 to 1.18), and they had higher odds of health-related unemployment (odds ratio, 2.94; 95 percent confidence interval, 1.90 to 4.57) and lower rates of marriage and parenthood (odds ratios [95 percent confidence intervals], 0.72 [0.63 to 0.84] and 0.60 [0.49 to 0.74], respectively).

"Results of this systematic review and meta-analysis suggest that childhood cancer survivors face significant long-term socioeconomic challenges, particularly in education, employment, and family formation compared with their peers," the authors write. "Establishment of a lifelong follow-up support protocol is crucially needed with a distinctive emphasis on successful social reintegration. To secure the future complete psychosocial well-being and fulfillment for the current generation of patients with childhood cancer, it is paramount to take immediate action."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted April 2024

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Vaginal Cancer Incidence Increasing Globally

WEDNESDAY, July 3, 2024 -- The incidence of vaginal cancer is increasing globally, according to a study published online June 25 in BJOG: An International Journal of Obstetrics...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.